Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Citi
Baxter
Teva
Medtronic
Queensland Health

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for ABX464

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for ABX464

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ABX464 ➤ Sign Up Compounds useful for treating AIDS ABIVAX (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris, FR) INSTITUT CURIE (Paris, FR) UNIVERSITE DE MONTPELLIER (Montpellier, FR) ➤ Sign Up
ABX464 ➤ Sign Up Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging ABIVAX (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris, FR) INSTITUT CURIE (Paris, FR) UNIVERSITE DE MONTPELLIER (Montpellier, FR) ➤ Sign Up
ABX464 ➤ Sign Up Treatments to eliminate HIV reservoirs and reduce viral load INSTITUT PASTEUR (Paris, FR) ➤ Sign Up
ABX464 ➤ Sign Up Quinoline derivative for use in the treatment and prevention of viral infections ABIV AX (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris, FR) INSTITUT CURIE (Paris, FR) UNIVERSITE DE MONTPELLIER (Montpellier, FR) ➤ Sign Up
ABX464 ➤ Sign Up Compounds useful for treating cancer ABIVAX (Paris, FR) CENTRE NATIONALE DE RECHERCHE SCIENTIFIQUE (Paris, FR) INSTITUT CURIE (Paris, FR) UNIVERSITE MONTPELLIER 2 (Montpellier, FR) ➤ Sign Up
ABX464 ➤ Sign Up Compounds useful for treating AIDS ABIVAX (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris, FR) INSTITUT CURIE (Paris, FR) UNIVERSITE DE MONTPELLIER 2 (Montpellier, FR) ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for ABX464

Drugname Country Document Number Estimated Expiration Related US Patent
ABX464 Australia 2010258214 2029-06-12 ➤ Sign Up
ABX464 Australia 2010258294 2029-06-12 ➤ Sign Up
ABX464 Australia 2010258295 2029-06-12 ➤ Sign Up
ABX464 Australia 2015203256 2029-06-12 ➤ Sign Up
ABX464 Australia 2017202500 2029-06-12 ➤ Sign Up
ABX464 Australia 2019203896 2029-06-12 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
AstraZeneca
Daiichi Sankyo
Accenture
Chubb
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.